spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

6th Annual Cancer Vaccines Conference

SMI - 6th annual Cancer Vaccines Conference

27-28 September 2017
Copthorne Tara Hotel, London UK

Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.

SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.

Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 6th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more.

Join us this September for strategic direction on vaccine commercialisation and arm yourself with the key requirements and tools for successful vaccine development through informed guidance delivered by a top panel of speakers.

Featured Speakers:

Steve Doberstein, Senior Vice President and Chief Scientific Officer, Nektar
Kandeepan Ganeshalingam, Executive Director, Therapeutic Area Head Oncology, MSD
Fatema Legrand, Senior Clinical Scientist, Genentech
David Giljohann, CEO, Exicure
Steve Doberstein, Senior Vice President and Chief Scientific Officer, Nektar
Agnete Fredriksen, Chief Scientific Officer, Vaccibody
Mads Hald Andersen, Professor and Vice-Director, Centre for Cancer Immune Therapy, Copenhagen University Hospital; Founder, IO Biotech
Rose-Ann Padua, Research Director, INSERM
Zahra Jawad, Group Leader in Discovery Technology, Agenus

Exclusive highlights in 2017:

Exploring personalising cancer vaccines, characterising and applying the outside in approach in cancer vaccine development
Maximising the therapeutic potential of cancer vaccines in combination with immune checkpoint inhibitors
In depth case study examples of peptide, DNA, neoantigen and MHC based vaccine development
Assessing the use of preclinical data for cancer vaccines

Cancer Vaccines 2017 is sponsored by Northwest Biotherapeutics
phone +44 (0) 207 827 6012
email kwilliams@smi-online.co.uk
web bit.ly/2rAmHA3
email Copthorne Tara Hotel, London
 
Print this page
Send to a friend
   
spacer
Industry Events

PPMA Show 2017

26-28 September 2017, NEC, BIRMINGHAM UK

The PPMA is the UK's trade association for suppliers of processing and packaging machinery to the UK market and represents over 500 member and associate companies. Its principle objective is to promote sales of machinery, both at home and abroad, through various projects and services of mutual benefit to both members and their customers by providing free technical and machinery information and advice.
More info >>

White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>


News and Press Releases

McKesson Specialty Health Achieves over 100 Audits without a Single Observation


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement